Retatrutide activates three hormone receptors at once: GLP-1R (reduces appetite, stimulates insulin), GIPR (boosts insulin and modulates appetite via a separate brain pathway), and GCGR (increases calorie burning and fat breakdown)
The most famous example of this trend, of course, is the discovery that GLP-1 drugs represent a legitimate treatment for patients who are overweight or obese
However, CJC-1295 supports the broader hormonal ecosystem in several important ways: Indirect Pathways to Better Testosterone Function A study in Endocrine Reviews noted that GH and IGF-1 play a permissive role in reproductive endocrinology, supporting the cellular environment where testosterone production occurs, even though they do not directly stimulate it (Hull & Harvey, 2014)
(2020) 142:e26586
While adverse events were slightly more frequent in the treatment group, serious safety outcomes, including fatalities, were similar between groups
Target fluid intake should be individualized based on your needs and medical conditions